ALS Texas

  • Facebook
  • Instagram
  • Pinterest
  • Twitter
  • Newsletter
  • Find Services
  • Understanding ALS
    • ALS Symptoms
    • Stages of ALS
    • What Causes ALS?
    • Lou Gehrig and the History of ALS
    • ALS Glossary
  • Who We Are
    • What We Do
    • Our Leadership
    • Financial Information
    • Our Partners
    • Careers
  • Research
    • How ALS Patients Can Help
    • Research Resources
    • Research News
    • ALS Association Research
  • Navigating ALS
    • Newly Diagnosed
      • What Do I Do Now?
      • How to Share Your Diagnosis
      • Second Opinions
      • Resources
      • Clinics and Centers
    • Living with ALS
      • For Patients
      • Therapies & Care
        • Nutrition & Feeding Tubes
        • How to Improve Mobility
        • Dealing with Breathing Issues
        • Dealing with Speech & Swallowing Issues
        • Types of Assistive Equipment & Technology
        • Clinics and Centers
      • Living Setting
      • Daily Living Activities
      • Leisure Activities
      • Accessible Vehicles
      • More in Depth Resources/Manuals
    • Coping with ALS
      • Dealing with Anxiety/Depression
      • Changes in Thinking & Emotional Lability
      • Support Groups
      • Resources
    • For Caregivers
      • Caregiver Program
      • Caregiver Resources
      • Practicing Self Care
      • From One Caregiver To Another
    • For Youth & Children
    • Virtual Support Groups & Workshops
      • Past Virtual Event Recordings
    • Resources
      • Healthcare/Insurance
      • Hospice & Palliative Care
      • Finances/Employment
      • Taxes
      • Advance Directives
      • More in Depth Resources/Manuals
      • Register with ALS Texas
  • Contact Us
  • Donate
    • Ways to Donate to ALS Texas
    • Corporate Partnerships
    • Workplace Giving
    • Community Giving Programs
  • Advocate
    • Advocacy Day
    • Advocacy News
  • Get Involved
    • Walk to Defeat ALS®
      • Register for a Walk
    • Texas Chapter Events
      • Houston Marathon and Half Marathon
      • All In For ALS Poker Tournament
      • Sporting Clay Shoot
      • Under Ballou Skies Golf Classic and Party
      • ALS Fishing Classic
      • The Cowtown Affair
    • Fundraising Opportunities
    • Calendar of Events
    • Volunteer
    • The ALS Ice Bucket Challenge

ALS Association Awards $1 Million to Fund Potential ALS Treatment

November 28, 2018 by Jacque Amadi 2 Comments

Today marks a monumental day for ALS research as the first in-human clinical trials of AT-1501 have begun. AT-1501 is an antibody therapeutic developed by the ALS Therapy Development Institute (ALS TDI), with support from The ALS Association, ALS ONE, and ALS Finding a Cure®. The drug blocks immune cell activation and protects nerves against the progression of ALS. As of today researchers at Anelixis Therapeutics, lead by Dr. Steve Perrin, have successfully administered a dose of AT-1501 to the study’s first participant.

This is a great progressive step on our journey for a cure, and we’re happy to announce that the ALS Association awarded an additional $1 million to Anelixis to help fund this groundbreaking research.

“We are proud to partner with Anelixis and other ALS organizations to help advance this promising compound into clinical trials,” said Calaneet Balas, President and CEO of The ALS Association.

The safety trial of this potentially new treatment is currently enrolling volunteers, both those with ALS and those without, to participate in the study. In total, eight people with ALS will receive AT-1501 and will be monitored for safety , tolerability, and how the drug moves through the body. If it’s proven safe the trial will then move on to Phase II.

We’re excited for the prospect of this new treatment and we remain hopeful that together with patients, caretakers, donors, and researchers we can create a world without ALS.

Help us create a world without ALS by donating today.

Filed Under: Research, Research News Tagged With: news, Research, research news

“Spark Hope For a World Without ALS” – Our 2018 Recap

November 27, 2018 by Jacque Amadi Leave a Comment

In 2018 we set out with the goal to spark hope, ignite action, and inspire others to join us in the fight to create a world without ALS. And it was thanks to our wonderful community that we were able to achieve that goal. Throughout the year we provided patient services, hosted community events, and helped fund life-changing research to find new treatments for this devastating disease.

[Read more…]

Filed Under: Fundraising, Research Tagged With: ALS News, ALS Research, ALS Texas, fundraising, walk to defeat als

Dodgeball Tournament Raises Over $55,000 in Three Years to Support ALS Research

June 27, 2017 by Elise Bernard 1 Comment

ALS dodgeball tournament hosts

Three days before Christmas 2009, Turner Corbett’s family got the devastating news that his mom, Jennifer, had been diagnosed with ALS. Turner was just 12 years old.

Wanting to make the most of a difficult situation, in 2015, Turner created a benefit event that would raise money for ALS research. After running through some ideas with his friend Alex Doswell, they decided a dodgeball tournament would be the most fun and family friendly.

[Read more…]

Filed Under: Fundraising, Research Tagged With: advocacy, als, ALS awareness, ALS Research, als stories, ALS Texas, fundraising, pals, Research

Frequently Asked Questions about Radicava™ (Edaravone)

May 6, 2017 by Tanner Hockensmith 21 Comments

Based on information as of 5/5/2017

What is Radicava?

Radicava™ (edaravone) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) to treat people with amyotrophic lateral sclerosis (ALS).1

In clinical trials, some people given Radicava showed significantly less decline in physical function compared to placebo as measured by the ALS Functional Rating Scale-Revised (ALSFRS-R), a validated rating instrument for monitoring the progression of disability in patients with ALS.1,2

[Read more…]

Filed Under: Research, Research News Tagged With: als, ALS drug, ALS News, ALS Research, ALS Research Update, ALS treatment, FDA, Research, research news

FDA Approves New ALS Drug

May 5, 2017 by Tanner Hockensmith 3 Comments

Radicava is First Approved Treatment for ALS in Decades

The Food and Drug Administration’s (FDA) announced today that it has approved Radicava (edaravone), the first new treatment approved specifically for ALS in 22 years. The FDA approved Radicava less than a year after Mitsubishi Tanabe Pharma Corporation submitted a New Drug Application. The only other approved treatment specifically for ALS, riluzole, was approved in 1995.

“We thank the FDA and MT Pharma for working together to expedite the approval of the first new ALS-specific treatment in decades,” said Barbara Newhouse, president and CEO of The ALS Association. “We hope today’s announcement signals the beginning of a new chapter in the fight against this terrible disease. There are several drugs to treat ALS currently in clinical trials and we are hopeful that people living with ALS have even more therapies available to them sooner rather than later.”

[Read more…]

Filed Under: Research, Research News Tagged With: als, ALS drug, ALS News, ALS Research, ALS Research Update, ALS treatment, FDA, national als advocacy day, Research, research news

New Research Brings Help, Hope to People with ALS

May 5, 2017 by Tanner Hockensmith Leave a Comment

ALS is a devastating disease with no cure.

But researchers are working to change that. The increased awareness and donations provided by events like the ALS Ice Bucket Challenge—and by people like you—are making a real difference in the pace of discoveries, bringing us ever closer to the end of ALS.

Here are just a few examples of recent advancements in ALS research and technology:

[Read more…]

Filed Under: Research Tagged With: als, ALS awareness, als cure, ALS Research, ALS Research Update, ALS treatment, biomarker, Research, research news

How Your Donations Impact Local ALS Research

December 20, 2016 by Elise Bernard Leave a Comment

The ALS Association funds the world’s largest ALS research program, working with more than 150 labs around the globe. The ALS Association supports a wide breadth of specific fields of study that are critical to advancing ALS research.

A significant portion of the research funded by the ALS Association is done through the vast network of clinical research and clinical trials. The ALS Association funds a nation-wide network of Certified Treatment Centers of Excellence, which must meet the ALS Association’s clinical care and treatment standards based on the American Academy of Neurology Practice Parameters. In order to achieve this certification, the clinic must participate in ALS-related research and successfully complete a comprehensive site review.

[Read more…]

Filed Under: Research Tagged With: als, als clinics, als cure, ALS drug, ALS Research, ALS Texas, ALS treatment, biomarker, clinical trial, clinics, Donate, Research

New Gene Discovered that Contributes to ALS

July 25, 2016 by Elise Bernard 1 Comment

$1 Million Grant from Ice Bucket Challenge Helped Spur Discovery

Today, researchers from Project MinE announced that they have identified a new gene NEK1 that ranks among the most common genes that contribute to ALS. The study revealed an association between mutations in the gene and ALS. The discovery of NEK1 gives scientists an exciting new target for drug development.

Approximately 10 percent of ALS cases are familial, meaning genes are inherited from a family member. The other 90 percent of ALS cases are sporadic, or without a family history. The NEK1 gene is present in approximately 3 percent of all ALS cases.

[Read more…]

Filed Under: Ice Bucket Challenge, News, Research, Research News Tagged With: als, ALS gene, ALS Research, ice bucket challenge, NEK1, Project MinE

Congress Takes Action on ALS Priorities

July 5, 2016 by Elise Bernard Leave a Comment

Thanks to nationwide advocacy efforts, Congress is taking action on several priorities for the ALS Community.

The Senate Appropriations Committee passed the fiscal year 2017 Health and Human Services spending bill and included $10 million to continue funding to the National ALS Registry. The National ALS Registry is a congressionally directed registry for people in the U.S. with ALS. It is a program to collect, manage, and analyze data about people with living with ALS, which helps doctors and scientists learn more as they work toward a cure. It is the only population-based registry in the U.S.

[Read more…]

Filed Under: Advocacy, News, Research, Research News Tagged With: advocacy, als, ALS Advocacy, ALS Registry, ALS Research

FDA Approval Sought for New ALS Drug

June 28, 2016 by Elise Bernard 9 Comments

Pharmaceutical company Mitsubishi Tanabe Pharma Corporation submitted a formal proposal to the United States Food and Drug Administration for approval of a drug to treat ALS. The drug, Edaravone, gets rid of toxic waste that is a normal by-product of cell function. It is thought that this waste is not as effectively removed in ALS patients, causing damage to motor neurons, which are the cells that die in ALS patients. Edaravone would protect these neurons by helping rid the cells of this waste.

The Edaravone new drug application is supported by clinical research with ALS patients in Japan, and in 2015, Edaravone was approved as a treatment for ALS in Japan and South Korea. After being submitted to the FDA for consideration, it could either be automatically approved for use in the U.S., or it could require a Phase III study conducted in the U.S.

[Read more…]

Filed Under: News, Research, Research News Tagged With: als, ALS drug, ALS Research, ALS Research Update, ALS treatment, FDA, Research, research news

  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
  • Site Map
  • Privacy Policy
  • Link Policy
  • Contact Us

The ALS Association of Texas | 877.714.0088
All content and works posted on this website are owned and copyrighted by the ALS Association of Texas © 2019


Dallas Office 14555 Dallas Parkway Suite 100-219, Dallas, Texas 75254
San Antonio Office We're working from home! Please send mail to the Dallas office.
Austin Office 2301 W Anderson Lane, Austin, TX, 78757
Houston Office 1213 Hermann Drive, Suite 525, Houston, Texas 77004